Karachi: Liven Pharma Limited has announced that its Letter of Rights has been declared eligible for inclusion in the Central Depository System (CDS), effective November 24, 2025. This development follows the company's correspondence with the Central Depository Company (CDC) of Pakistan, which issued a formal notice on November 21, 2025. The CDC's declaration was made under Regulation 8AA.2.2, thereby classifying the Right Entitlements of Liven Pharma Limited as CDS Eligible Securities.

According to information available from the Pakistan Stock Exchange (PSX), the CDS eligibility of the Letter of Rights is a significant step for Liven Pharma Limited. This status allows for an improved framework for the management and transfer of securities within the market, enhancing the transaction efficiency for the company’s shareholders.

The formal notice attached to Liven Pharma's announcement underscores the company's responsibility to comply with the CDC's regulatory requirements and procedures. The company is tasked with ensuring smooth integration of its Right Entitlements into the CDS, which is critical for maintaining transparency and efficiency in securities transactions.

Liven Pharma Limited's move to secure CDS eligibility is part of a broader strategy within the designated market category to optimize the handling of securities and fortify investor confidence. The declaration is anticipated to streamline processes for TREC holders of the Exchange, as informed by the company.